PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123C00192THIS IS a FIRM FIXED PRICE — Akina Inc

Akina Inc holds $1.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Akina Inc

Recipient

Dec 31, 2026

PoP end

$1.2M

Obligated

$1.2M

Potential

541714

NAICS

B504

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Akina Inc — $90

Contract facts

NONE

Contract number75F40123C00192

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAkina Inc

CAGE3ZDR8

UEIWTBLC3LE13U1

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCB504

Place of performanceWEST LAFAYETTE IN

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationFDABAA-23-00123

PoP startSep 26, 2023

PoP end (current)Dec 31, 2026

Obligated$1.2M

Current value$1.2M

Potential value$1.2M

THIS IS A FIRM FIXED PRICE FORNEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS. is a federal NONE award for Fda Office Of Acq Grant Svcs held by Akina Inc. Estimated value $1.2M ($1.2M obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: WEST LAFAYETTE IN. Related solicitation FDABAA-23-00123.

THIS IS A FIRM FIXED PRICE FORNEW PLGA ANALYTICAL METHODS FOR MINI-SIZE COMPLEX LONG-ACTING INJECTABLE FORMULATIONS.

Recompete timing

Public

● Expiring in 115 days

Current PoP ends Dec 31, 2026 (115 days remaining). Agencies typically plan 12–18 months ahead — at 3.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Akina Inc — $1.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$1.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40123C00192?

75F40123C00192 (THIS IS a FIRM FIXED PRICE) is a Fda Office Of Acq Grant Svcs award with a potential value of $1.2M, currently held by Akina Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123C00192?

Fda Office Of Acq Grant Svcs awarded 75F40123C00192 to Akina Inc (potential $1.2M).

Who is the incumbent on 75F40123C00192?

Akina Inc is the incumbent with $1.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Akina Inc’s 75F40123C00192 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40123C00192 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Dec 22, 2025